Skip to Content

In brief: VGM’s new sleep service, GoodRx’s diabetes milestone 

In brief: VGM’s new sleep service, GoodRx’s diabetes milestone 

WATERLOO, Iowa – VGM & Associates has officially launched Sleep Services, a CPAP setup and compliance program that aims to create relationships with patients for ongoing care and success, the company says. The program comprises no-touch delivery, onboarding, patient setup, compliance and post-compliance monitoring. “This program helps our members with staffing, revenue and patient compliance,” the company says. “By using Sleep Services as their outsourced clinical service, members/providers can be more efficient and reduce costs, as opposed to hiring additional clinicians. Sleep Services provides more efficiency and higher compliance rates.” Among the features of the program are an ala carte list of services, including onboarding, setup, compliance and post-compliance; bi-directional communication; and an assigned personal care coordinator. It offers no-touch delivery in conjunction with VGM Fulfillment. 

GoodRx hits milestone for diabetes 

SANTA MONICA, Calif. - GoodRx says it has helped almost 2.5 million Americans save more than $500 million on diabetes treatments to date. The company says, for example, that its customers saved, on average, 37% on continuous glucose monitors, including the Dexcom G6 and G7, FreeStyle Libre, Libre 2 and Libre 3. “Managing a chronic condition can be incredibly expensive and time consuming – so much so, we’ve seen the cost of supplies and prescriptions used to manage diabetes impact which treatment plan patients opt for,” said Karla Robinson, MD, medical editor at GoodRx. “By providing incredible savings and information in one place, GoodRx is an invaluable resource for those living with diabetes to help them more easily access and afford the proper treatment they need.” While there are recent efforts to curb the prices of insulin, GoodRx Research shows the average cash price for insulin rose 54% from 2014-19 and only decreased 7.1% from 2020-23. There’s a significant economic burden that comes with a diabetes diagnosis, the company says, with costs potentially exceeding $5,800 per year when factoring in medications, doctor visits, outpatient care and self-care to control blood glucose levels. 

Prochant makes Inc. 5000 list 

CHARLOTTE – Prochant has earned a spot on the Inc. 5000 list of fastest-growing private companies in the United States for the third consecutive year, the company has announced. "At Prochant, we've redefined innovation in the home-based care sector by incorporating human-in-the-loop AI tools into healthcare revenue cycle management,” said Mathew Mammen, CEO. “Our third-time inclusion on the Inc. 5000 list is a testament to our unwavering growth and the harmonious fusion of cutting-edge technology with a dedicated team of over 2,000 revenue cycle experts. Partnering with Prochant means harnessing the true power of AI-driven solutions, where technology and human expertise converge seamlessly. Embrace the future with us – together, we're reshaping healthcare revenue cycles for optimal efficiency and patient-centered care.” Companies on the 2023 Inc. 5000 are ranked according to percentage revenue growth from 2019 to 2022. To qualify, companies must have been founded and generating revenue by March 31, 2019. They must be U.S.-based, privately held, for-profit, and independent as of Dec. 31, 2022. The minimum revenue required for 2019 is $100,000 and the minimum for 2022 is $2 million. In all, the health care products and services companies on the list have a median growth of 297%, $27.5 billion in revenue, 79,683 jobs added and 206 repeat honorees. 

Densow’s works through bankruptcy process 

RICHLAND, Wash. - Washington Medical Supplies, doing business as Densow’s Medical Supplies, has filed for Chapter 11 bankruptcy protection, but it remains open for business, according to a local newspaper. Co-owner Lisa Lewis told the Tri-Cities Area Journal that the company has actually tripled its revenues in recent years. “I’m hopeful for the future,” she told the newspaper. “I have an amazing team and we work as hard as we can every single day to ensure the success of the business. I’m looking forward to, in the next year, this being in the rear view. It will be a blip as we move forward.” Lewis told the newspaper that Densow’s financials have been impacted by ongoing litigation with the company’s previous owners over billing errors, as well as the COVID-19 pandemic. Densow’s has operated in Richland since 1949. It focuses on complex rehab products, as well as lift chairs, ramps, scooters and standard wheelchairs. It also provides wound care, ostomy, incontinence and urological supplies and compression garments. 


To comment on this post, please log in to your account or set up an account now.